Study Highlights Complex Role of IL-13 Among Patients with Bullous Pemphigoid
This analysis suggests serum IL-13 levels are lower in bullous pemphigoid patients than in healthy controls and pemphigus vulgaris patients.
Related Articles
Adults with Severe Alopecia Improve Anxiety, Depression with Deuruxolitinib Use
These pooled THRIVE-AA1 and THRIVE-AA2 study data highlight improvements in mental health among patients with alopecia given deuruxolitinib.
Clinical Pearls on Managing Allergic Contact Dermatitis, with April Martinez-Dulay, MSN, APRN, FNP-C
During this DERM 2025 interview segment, Martinez-Dulay touches on highlights from her sessions in which she explores allergic contact dermatitis.
Highlighting Recent Topical Options for Psoriasis, with Linda Stein Gold, MD
In a new interview at the DERM2025 Conference, Stein Gold highlighted several topical options for patients with psoriasis outside of topical steroids.
Study Identifies Triggers Beyond GI Infections for Pediatric p-DGBI
A new study highlights stress, concussion, and other early-life factors as key contributors to pediatric pain-predominant DGBIs.
Walking 7000 Steps Per Day Reduces Risk of Chronic Diseases, Cognitive Decline
Findings suggest 7000 steps per day is associated with a reduced risk of health outcomes including mortality, cardiovascular disease, and type 2 diabetes.
Strategies for Differentiating Hair Loss Disorders from Alopecia Areata
This session was titled ‘The Hidden Undercurrent: When Hair Loss Isn’t Alopecia Areata’ and was presented at the DERM 2025 conference by April Armstrong, MD,…
Pharmacist Education Eases Allergic Rhinitis Symptoms but Can’t Replace Care
A randomized trial found pharmacist-led counseling improved allergic rhinitis symptom control but did not enhance adherence, knowledge, or quality of life.
HCPLive – Clinical news for connected physicians
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.
Patient-Reported Hair Satisfaction with Deuruxolitinib for Severe Alopecia Areata
This summary highlights changes in severe alopecia areata following deuruxolitinib therapy during THRIVE-AA1 and THRIVE-AA2.
Managing Atopic Dermatitis and Prurigo Nodularis, with April Martinez-Dulay, MSN, APRN, FNP-C
In her DERM 2025 conference interview, Martinez-Dulay highlights takeaways from her sessions on atopic dermatitis, prurigo nodularis, and lymphoma.